106.34
前日終値:
$115.43
開ける:
$107.5
24時間の取引高:
2.32M
Relative Volume:
1.32
時価総額:
$8.12B
収益:
$8.10B
当期純損益:
$599.48M
株価収益率:
14.38
EPS:
7.3969
ネットキャッシュフロー:
$971.25M
1週間 パフォーマンス:
-7.99%
1か月 パフォーマンス:
+5.97%
6か月 パフォーマンス:
-40.92%
1年 パフォーマンス:
-25.70%
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ICLR
Icon Plc
|
106.34 | 8.80B | 8.10B | 599.48M | 971.25M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
466.70 | 173.44B | 45.20B | 6.88B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
178.57 | 126.39B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
560.93 | 44.55B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
114.42 | 32.34B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
311.20 | 30.55B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-26 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | アップグレード | Jefferies | Hold → Buy |
| 2026-02-18 | アップグレード | TD Cowen | Hold → Buy |
| 2026-02-17 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2026-02-12 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | ダウングレード | Truist | Buy → Hold |
| 2025-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-09-09 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-03 | アップグレード | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-07-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-04-14 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-03-21 | ダウングレード | Goldman | Buy → Neutral |
| 2025-01-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 開始されました | Redburn Atlantic | Neutral |
| 2024-09-18 | 開始されました | Leerink Partners | Outperform |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2023-12-15 | 開始されました | Truist | Buy |
| 2023-09-13 | 開始されました | TD Cowen | Outperform |
| 2023-01-17 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-01-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-11-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-09-07 | 開始されました | UBS | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2021-09-27 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-14 | 開始されました | Citigroup | Neutral |
| 2021-04-13 | 再開されました | BofA Securities | Neutral |
| 2021-04-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 開始されました | Barclays | Equal Weight |
| 2021-03-01 | アップグレード | UBS | Neutral → Buy |
| 2021-02-26 | アップグレード | Truist | Hold → Buy |
| 2020-07-24 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-04-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 開始されました | Deutsche Bank | Hold |
| 2020-01-27 | ダウングレード | SunTrust | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-09-23 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | アップグレード | UBS | Sell → Neutral |
| 2019-01-25 | アップグレード | Mizuho | Neutral → Buy |
| 2018-10-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 開始されました | UBS | Sell |
| 2018-04-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 繰り返されました | Mizuho | Neutral |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
| 2017-10-27 | 繰り返されました | Barclays | Equal Weight |
| 2017-09-11 | 開始されました | BofA/Merrill | Buy |
| 2017-07-31 | アップグレード | SunTrust | Hold → Buy |
| 2017-07-27 | 繰り返されました | Mizuho | Neutral |
| 2017-06-29 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Icon Plc (ICLR) 最新ニュース
A Look at Icon PLC (ICLR) After 7.9% Decline -- GF Value $243.03 vs Price $106.34 - GuruFocus
ICON (ICLR) slides as investors stay cautious ahead of delayed results tied to accounting review - Quiver Quantitative
Icon (NASDAQ:ICLR) Shares Gap DownShould You Sell? - MarketBeat
Pre-Market Movement | Icon PLC Falls Nearly 7% in Pre-Market Trading - 富途牛牛
Is ICON plc (ICLR) stock cheap relative to earnings growth | ICON plc Posts 1.2% EPS Miss On Solid Quarterly Revenue - Xã Thanh Hà
M&T Bank Corp Has $31.50 Million Holdings in Icon Plc $ICLR - MarketBeat
16,248 Shares in Icon Plc $ICLR Purchased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
ICLR (ICON plc Ordinary Shares) falls 0.79% following Q3 2025 slight EPS miss and modest 2% year over year revenue growth.Operating Margin - Cổng thông tin điện tử tỉnh Tây Ninh
Icon (ICLR) to Release Quarterly Earnings on Wednesday - MarketBeat
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
ICON plc options imply 11.5% move in share price post-earnings - TipRanks
Hudson Edge Investment Partners Inc. Has $47.46 Million Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Analysis: Potential Upside with Strategic Global Reach Captivates Investors - DirectorsTalk Interviews
Icon PLC (MEX:ICLRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
MEX:ICLRN EV-to-EBIT: 13.38 — 37% Below Median - GuruFocus
Icon PLC (MEX:ICLRN) Stock Price & 30 Year Financial Data - GuruFocus
Icon Plc $ICLR Shares Sold by Ninety One UK Ltd - MarketBeat
Ninety One North America Inc. Purchases 12,552 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Fisher Funds Management LTD - MarketBeat
ICON plc options imply 9.7% move in share price post-earnings - TipRanks
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $120 - 富途牛牛
ICON plc stock (IE0005711209): Why its clinical trial dominance matters more now for U.S. investors? - AD HOC NEWS
ICON Launches New Functional Service Provision (FSP) Strategy - AOL.com
USS Investment Management Ltd's Icon PLC(ICLR) Holding History - GuruFocus
Is It Too Late to Buy Icon PLC (ICLR) After 3.0% Rally? GF Value Says Undervalued - GuruFocus
Icon Plc (NASDAQ:ICLR) Short Interest Update - MarketBeat
Timber Creek Capital Management LLC Makes New $5.65 Million Investment in Icon Plc $ICLR - MarketBeat
Is ICON (NasdaqGS:ICLR) Offering An Opportunity After Recent Share Price Volatility? - Sahm
ICON plc stock (IE0005711209): Is clinical trial demand strong enough to drive U.S. investor upside? - AD HOC NEWS
Massachusetts Financial Services Co. MA Has $429.50 Million Holdings in Icon Plc $ICLR - MarketBeat
ALTRINSIC GLOBAL ADVISORS LLC's Icon PLC(ICLR) Holding History - GuruFocus
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neogen (NEOG) - The Globe and Mail
What does insider activity suggest for ICON plc (ICLR) Stock | Price at $104.66, Down 1.92%Trending Social Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $180 - 富途牛牛
Trinity Street Asset Management LLP Increases Stock Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Forecasts - Yahoo! Finance Canada
ICON Public Limited Company (ICLR) stock price, news, quote and history - Yahoo Finance UK
Icon Plc $ICLR Shares Acquired by Aberdeen Group plc - MarketBeat
Downgrading Icon's Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
Icon: Downgrading Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative - simplywall.st
Healthcare Rpo Market Is Going to Boom | • ICON plc • Syneos Health • Labcorp - openPR.com
ICLR Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Fund Update: 1,985,017 ICON PLC (ICLR) Shares Added to GREENHAVEN ASSOCIATES INC Portfolio - Moomoo
Fund Update: 1,985,017 ICON PLC (ICLR) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Walter Public Investments Inc.'s Icon PLC(ICLR) Holding History - GuruFocus
A Look At ICON (ICLR) Valuation After Q1 Earnings Miss And Recent Share Price Volatility - simplywall.st
ICON PLC earnings missed by $0.02, revenue was in line with estimates - Investing.com South Africa
Icon (ICLR) Dividend-Payout-to-FFO - GuruFocus
ICLR 3-Year EBITDA Growth Rate: 28.40% — 176% Above Median - GuruFocus
Icon Plc (ICLR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):